ERIS Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 442.37 | 461.85 | 361.69 |
| Operating Expense | 293.93 | 333.31 | 261.91 |
| Net Profit | 28.10 | 17.04 | 39.51 |
| Net Profit Margin | 6.35 | 3.69 | 10.92 |
| Earning Per Share | 2.06 | 1.25 | 2.90 |
| EBIDTA | 139.30 | 123.45 | 105.78 |
| Effective Tax Rate | 5.91 | 3.65 | 8.26 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 442.37 |
| Operating Expense | 293.93 |
| Net Profit | 28.10 |
| Net Profit Margin | 6.35 |
| Earning Per Share | 2.06 |
| EBIDTA | 139.30 |
| Effective Tax Rate | 5.91 |
Invest in ERIS Lifesciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,486.71 | 1,330.73 | 1,215.73 |
| Operating Expenses Annual | 1,032.89 | 825.61 | 731.74 |
| Operating Profit Annual | 488.64 | 522.38 | 512.98 |
| Interest Annual | 57.42 | 20.81 | 2.99 |
| Depreciation | 34.15 | 29.76 | 51.46 |
| Net Profit Annual | 299.71 | 398.01 | 417.19 |
| Tax Annual | 29.12 | 38.90 | 41.35 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,486.71 |
| Operating Expenses Annual | 1,032.89 |
| Operating Profit Annual | 488.64 |
| Interest Annual | 57.42 |
| Depreciation | 34.15 |
| Net Profit Annual | 299.71 |
| Tax Annual | 29.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 47.48 | 44.70 | 31.35 |
| Cash Flow from Operations | 336.29 | 322.33 | 369.41 |
| Cash Flow from Investing | -2,491.89 | -513.30 | -267.64 |
| Cash Flow from Financing | 2,160.06 | 193.75 | -88.42 |
| Cash Flow at the End | 51.94 | 47.48 | 44.70 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 47.48 |
| Cash Flow from Operations | 336.29 |
| Cash Flow from Investing | -2,491.89 |
| Cash Flow from Financing | 2,160.06 |
| Cash Flow at the End | 51.94 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 31.97 | 38.97 | 42.20 |
| PBIT Margin (%) | 25.27 | 34.15 | 37.97 |
| PBT Margin (%) | 24.83 | 32.51 | 25.52 |
| Net PROFIT Margin (%) | 19.61 | 29.69 | 34.32 |
| Return On Networth / Equity (%) | 12.63 | 19.23 | 23.88 |
| Return On Networth /Employed (%) | 9.98 | 19.94 | 25.68 |
| Return On Assets (%) | 7.65 | 17.22 | 23.33 |
| Total Debt / Equity (X) | 0.60 | 0.08 | TBA |
| Asset Turnover Ratio (%) | 0.39 | 0.58 | 0.68 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 31.97 |
| PBIT Margin (%) | 25.27 |
| PBT Margin (%) | 24.83 |
| Net PROFIT Margin (%) | 19.61 |
| Return On Networth / Equity (%) | 12.63 |
| Return On Networth /Employed (%) | 9.98 |
| Return On Assets (%) | 7.65 |
| Total Debt / Equity (X) | 0.60 |
| Asset Turnover Ratio (%) | 0.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,516.17 | 898.16 | 644.99 |
| Total Current Assets Annual | 1,876.55 | 552.08 | 580.01 |
| Non Current Assets Annual | 3,473.02 | 2,231.58 | 1,570.41 |
| Total Shareholders Funds Annual | 2,524.02 | 2,221.88 | 1,918.56 |
| Total Assets Annual | 5,349.57 | 2,783.66 | 2,150.42 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,516.17 |
| Total Current Assets Annual | 1,876.55 |
| Non Current Assets Annual | 3,473.02 |
| Total Shareholders Funds Annual | 2,524.02 |
| Total Assets Annual | 5,349.57 |
EPS (INR)
Expected
6.73
Reported
6.73
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
